Touch hypersensitivity - Causes, Treatment & When to See a Doctor

```html

What is Touch hypersensitivity?

Touch hypersensitivity, also called tactile hyperesthesia or cutaneous hyperalgesia, is an abnormal increase in sensitivity to light touch, pressure, or temperature. People with this symptom may experience pain, itching, burning, or an uncomfortable “tingling” sensation from stimuli that most individuals perceive as gentle or even non‑painful. The heightened response can be localized (affecting a specific body part) or widespread, and it may fluctuate in intensity over time.

Touch hypersensitivity is not a disease itself; it is a sign that the nervous system—particularly the peripheral or central pathways that convey tactile information—is altered. Understanding the underlying cause is essential for targeted treatment.

Common Causes

Numerous medical conditions can provoke tactile hyperesthesia. Below are the most frequently encountered causes:

• Neuropathic disorders – e.g., peripheral neuropathy from diabetes, chemotherapy, or vitamin B12 deficiency.
• Fibromyalgia – a chronic pain syndrome characterized by widespread tenderness and sensory amplification.
• Complex Regional Pain Syndrome (CRPS) – a severe, often limb‑focused, pain condition following injury or surgery.
• Multiple Sclerosis (MS) – demyelinating lesions in the central nervous system can disrupt sensory processing.
• Post‑herpetic neuralgia – lingering nerve pain after a shingles (herpes zoster) infection.
• Autoimmune disorders – such as systemic lupus erythematosus or Sjögren’s syndrome, which may affect peripheral nerves.
• Infections – Lyme disease, HIV, or leprosy can damage sensory nerves.
• Dermatologic conditions – eczema, psoriasis, or contact dermatitis that inflame the skin and sensitize nerve endings.
• Migraine aura or chronic migraine – some patients report cutaneous allodynia (pain from non‑painful touch) during attacks.
• Medication side‑effects – certain antidepressants, anticonvulsants, or immune‑modulating drugs may induce sensory disturbances.

Associated Symptoms

Touch hypersensitivity often co‑exists with other sensory or systemic signs, helping clinicians narrow the underlying diagnosis. Common companions include:

• Pain or burning sensations – may be constant or triggered by light pressure.
• Allodynia – pain caused by normally non‑painful stimuli such as a light brush of a cloth.
• Hyperesthesia – an exaggerated sense of touch, temperature, or vibration.
• Itching (pruritus) – especially with dermatologic conditions.
• Muscle weakness or fatigue – seen in neuropathies and fibromyalgia.
• Changes in skin colour or temperature – bluish hue, swelling, or sweating over the affected area (common in CRPS).
• Coordination difficulties – when proprioceptive (position) sense is altered.
• Fatigue, sleep disturbance, mood changes – especially in chronic pain syndromes.

When to See a Doctor

While occasional heightened skin sensitivity can be benign, certain patterns warrant prompt medical evaluation:

• Sudden onset of severe touch‑induced pain, especially after an injury, surgery, or infection.
• Progressive worsening or spreading of symptoms.
• Accompanying neurological signs such as weakness, numbness, vision changes, or balance problems.
• Fever, rash, or swelling together with hypersensitivity (possible infection or inflammatory process).
• Symptoms that interfere with daily activities, work, or sleep.
• History of diabetes, chemotherapy, or other systemic illnesses that increase the risk of neuropathy.

If any of the above are present, schedule an appointment with a primary‑care physician or a neurologist promptly.

Diagnosis

Evaluating touch hypersensitivity involves a combination of patient history, physical examination, and targeted investigations.

1. Detailed Medical History

• Onset, duration, and pattern of the hypersensitivity.
• Associated triggers (cold, heat, stress, medications).
• Relevant past medical conditions (diabetes, autoimmune disease, infections).
• Medication and supplement list.
• Family history of neuropathic or autoimmune disorders.

2. Physical Examination

• Inspection of skin for lesions, colour changes, swelling.
• Quantitative sensory testing – using calibrated monofilaments or brushes to assess thresholds.
• Neurological exam – strength, reflexes, coordination, and gait.
• Special tests for allodynia (e.g., light cotton swab) and hyperalgesia (pinprick).

3. Laboratory Tests

• Blood glucose & HbA1c (diabetes screening).
• Vitamin B12, folate, thyroid panel.
• Autoimmune serologies – ANA, rheumatoid factor, anti‑SSA/SSB.
• Infectious work‑up if indicated – Lyme serology, HIV, VDRL.

4. Electrodiagnostic Studies

• Nerve conduction studies (NCS) and electromyography (EMG) – evaluate peripheral nerve function.
• Quantitative sensory testing (QST) – measures detection thresholds for vibration, temperature, and pain.

5. Imaging

• MRI of brain or spine when central causes (MS, tumor, spinal cord lesion) are suspected.
• Ultrasound or MRI of affected limb for CRPS or localized nerve entrapment.

6. Specialized Assessments

• Skin biopsy for intra‑epidermal nerve fiber density – useful in small‑fiber neuropathy.
• Autonomic testing (sweat test, heart‑rate variability) when dysautonomia is part of the picture.

Treatment Options

Treatment is directed at the underlying cause, relief of the hypersensitivity, and functional rehabilitation.

1. Pharmacologic Therapies

• Antidepressants – tricyclic antidepressants (amitriptyline 10–75 mg at night) or SNRIs (duloxetine 30–60 mg daily) can dampen pain pathways.
• Anticonvulsants – gabapentin (300‑1800 mg/day) or pregabalin (75‑300 mg/day) are first‑line for neuropathic pain.
• Topical agents – lidocaine 5 % patches or capsaicin 8 % cream to desensitize peripheral receptors.
• Opioids – reserved for severe, refractory cases and used under strict supervision.
• NMDA receptor antagonists (e.g., ketamine infusions) – occasional use in CRPS under specialist care.
• Immunomodulators – for autoimmune etiologies (e.g., hydroxychloroquine for lupus, IVIG for inflammatory neuropathies).

2. Physical & Occupational Therapy

• Gradual desensitization techniques – gentle brushing, graded exposure to textures.
• Mirror therapy and graded motor imagery for CRPS.
• Strengthening and range‑of‑motion exercises to prevent disuse atrophy.

3. Interventional Procedures

• Peripheral nerve blocks or stellate ganglion block for localized CRPS.
• Spinal cord stimulation (SCS) – implanted device delivering low‑level electrical currents to modulate pain signals.

4. Lifestyle & Home Management

• Maintain optimal blood glucose and vitamin levels.
• Use soft, breathable fabrics; avoid tight clothing or abrasive surfaces.
• Apply cool compresses or soothing lotions (calamine, aloe) for burning sensations.
• Stress‑reduction techniques—mindfulness, yoga, or biofeedback—can lower central sensitization.
• Regular low‑impact exercise (walking, swimming) improves circulation and nerve health.

5. Psychological Support

• Cognitive‑behavioral therapy (CBT) has proven benefit for chronic pain and hyperesthesia.
• Support groups for conditions like fibromyalgia or chronic neuropathic pain.

Prevention Tips

While some causes (genetic, post‑viral) are unavoidable, many risk factors are modifiable:

• Control chronic diseases – keep diabetes, hypertension, and cholesterol within target ranges.
• Protect nerves during medical treatments – discuss neuro‑protective strategies with oncologists before chemotherapy.
• Practice good skin hygiene – moisturize regularly to avoid dermatitis that can heighten tactile sensitivity.
• Avoid prolonged pressure or friction – use padded cushions, ergonomic tools, and change positions frequently.
• Vaccinate against shingles – the recombinant zoster vaccine reduces the risk of post‑herpetic neuralgia.
• Adopt a balanced diet – adequate B‑vitamins, omega‑3 fatty acids, and antioxidants support nerve health.
• Limit alcohol intake – excessive alcohol is a toxin for peripheral nerves.

Emergency Warning Signs

If you experience any of the following, seek immediate medical attention (call 911 or go to the nearest emergency department):

• Sudden, severe pain with swelling, redness, and warmth suggestive of infection or compartment syndrome.
• Rapidly spreading skin discoloration or ulceration.
• Difficulty breathing, chest tightness, or swelling of the face/neck (possible anaphylaxis to a topical agent).
• Loss of consciousness, severe headache, or new neurological deficits (e.g., weakness, vision loss) that could indicate stroke or severe CNS involvement.
• Fever > 38.5 °C (101.3 °F) accompanied by worsening skin pain, indicating possible sepsis.

---

References:

• Mayo Clinic. “Neuropathic pain: Diagnosis and treatment.” https://www.mayoclinic.org
• Cleveland Clinic. “Complex Regional Pain Syndrome (CRPS).” https://my.clevelandclinic.org
• National Institute of Neurological Disorders and Stroke. “Fibromyalgia Fact Sheet.” https://www.ninds.nih.gov
• CDC. “Shingles (Herpes Zoster) Vaccination.” https://www.cdc.gov
• World Health Organization. “Guidelines for the Management of Neuropathic Pain.” 2021. https://www.who.int
• American Academy of Neurology. “Diagnostic Evaluation of Peripheral Neuropathy.” Neurology. 2022;98(14):e1490‑e1505.

```